News

BioTox Sciences (BTS) Deploys eStudy™ Hosted Solution for Management of GLP & Non-GLP Preclinical Studies

CARY, N.C., March 9, 2011 /PRNewswire/ — iAdvantage Software, Inc., a leading solutions provider for managing development and pre-clinical life science studies, today announced that BioTox Sciences (BTS), a GLP Contract Research Organization, headquartered in San Diego, California, is deploying the eStudy™ hosted solution to manage its GLP and Non-GLP preclinical/nonclinical studies. (Logo: http://photos.prnewswire.com/prnh/20110309/CL62195LOGO )…

Read More

Apricus Biosciences Sells Bio-Quant CRO Subsidiary to BioTox Sciences

Company to Focus on Generation of Revenues From Commercialization of Drug Pipeline Based on NexACT(R) Delivery Technology SAN DIEGO, July 6, 2011 (GLOBE NEWSWIRE) — Apricus Biosciences, Inc. (“Apricus Bio”) (Nasdaq:APRI) announced today that it has sold its wholly-owned subsidiary, Bio-Quant, Inc. (“Bio-Quant”), a specialty biotechnology Contract Research Organization (“CRO”), to BioTox Sciences (“BioTox”), a…

Read More

BioTox Sciences FDA Audit News

SAN DIEGO, January 31, 2012 – BioTox Sciences is pleased to share that their most recent FDA audit was met with no deviations from the regulations. No observations, 483’s or findings were noted in the three and a half day inspection.

Read More

BioTox Sciences Attends the Society of Toxicology: Annual Meeting and Tox Expo

San Francisco, March 11-15, 2012 – BioTox Sciences attends the SOT’s Annual Meeting and Toxicology Expo at the Moscone Convention Center in San Francisco, California. The Annual Meeting is the premier event in the Toxicology community that addresses the latest achievements in Toxicology that have been accomplished within the last year.

Read More